COO Willem van Oort, PhD
Willem van Oort joined AIMM at its founding, bringing over 30 years of experience in business development and shaping and managing start-up companies. Previously, van Oort served as general manager of Licentec, a commercial technology transfer company, where he established more than 150 global R&D-alliances and licensing agreements. Van Oort founded and managed two seed capital funds and several university spin-offs including Pepscan, AMT, Add2X Biosciences, C-Très and Arthrogen. He was also founder of the Amsterdam Medical Center’s (University of Amsterdam) Technology Transfer Office.